扩散MRI影像组学预测ADPKD肾功能下降
该研究基于Bern ADPKD登记中112例患者的基线MRI(含扩散加权成像),提取ADC图影像组学特征,以支持向量机建模预测中位随访5.5年内的快速肾功能下降(eGFR≤-3 ml/min/1.73 m²/年)。ADC影像组学模型AUC达0.82,整合ADC、T1/T2w与临床数据的联合模型AUC为0.85,并改善风险重分类。
要点
- ADC影像组学预测ADPKD肾功能下降的AUC为0.82,优于临床模型和T1/T2w模型(均为0.77)。
- 整合ADC、T1/T2w与临床数据的联合模型AUC达0.85,校准改善且风险重分类提升。
- ADC影像组学提供超出ht-TKV和现有临床标准的增量预后信息,尚需独立队列验证。
核心结论
- ADC衍生影像组学特征对ADPKD肾功能下降具有预后价值,整合临床和常规MRI模型时提供增量信息。
研究设计与样本
- 分析Bern ADPKD登记中112例ADPKD患者的基线MRI(T1、T2和扩散加权),手动分割肾脏后用PyRadiomics提取影像组学特征。
- 特征经LASSO筛选,采用支持向量机建模并行20折交叉验证,结局为快速肾功能下降(eGFR≤-3 ml/min/1.73 m²/年),中位随访5.5年。
主要发现
- ADC影像组学模型AUC为0.82,临床模型和T1/T2w模型AUC均为0.77。
- 整合ADC、T1/T2w和临床数据的联合模型AUC最佳,为0.85,且校准改善。
- NRI分析显示将ADC信息纳入临床和常规MRI模型后风险重分类改善。
关键数值与推荐
- 快速肾功能下降定义为eGFR≤-3 ml/min/1.73 m²/年。
- ADC影像组学模型AUC:0.82;临床模型:0.77;T1/T2w模型:0.77;联合模型:0.85。
临床怎么用
- 在ADPKD风险分层中,ADC影像组学可补充ht-TKV和临床标准,辅助早期识别快速肾功能下降高危患者。
- 若获独立队列验证,扩散MRI影像组学可能支持更早的风险分层和治疗决策。
局限性
- 结论需在独立队列中验证。
- 样本来自单一登记(Bern ADPKD Registry),共112例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disorder and a leading cause of end-stage kidney disease (ESKD). Current risk stratification relies on height-adjusted total kidney volume (ht-TKV), which captures cyst burden but not alterations in the noncystic parenchyma. Radiomics enables extraction of quantitative features reflecting tissue microstructure across both cystic and noncystic kidney compartments. We investigated whether radiomic features from apparent diffusion coefficient (ADC) maps improve prediction of renal function decline in ADPKD. METHODS: We analyzed 112 patients with ADPKD from the Bern ADPKD Registry with baseline magnetic resonance imaging (MRI, T1-, T2-, and diffusion-weighted). Kidneys were manually segmented, and radiomic features were extracted using PyRadiomics. Features were selected using least absolute shrinkage and selection operator, and models were developed using support vector machines with 20-fold cross-validation. The outcome was rapid renal function decline (estimated glomerular filtration rate [eGFR] ≤ -3 ml/min per 1.73 m2/year) over a median follow-up of 5.5 years. RESULTS: ADC-based radiomics provided the highest area under the curve (AUC: 0.82), compared with clinical (0.77) and T1/T2w models (0.77). Ensemble models integrating ADC, T1/T2w, and clinical data achieved the best AUC (0.85) with improved calibration. Net reclassification improvement (NRI) analyses demonstrated improved risk reclassification when ADC-derived information was incorporated into clinical and conventional MRI-based models. CONCLUSION: ADC-derived radiomic features showed promising prognostic value for predicting renal function decline in ADPKD and provided incremental information beyond ht-TKV and current clinical standards when integrated with clinical and conventional MRI-based models, capturing both cystic and noncystic tissue alterations. If confirmed in independent cohorts, diffusion MRI-based radiomics may support earlier risk stratification and treatment decision-making in ADPKD.
引用
- Bargagli M, Altabella L, Fedon Vocaturo M, et al. Diffusion MRI Radiomics Predict Renal Function Decline in ADPKD. Kidney Int Rep. 2026. PMID: 42662913. doi:10.1016/j.ekir.2026.106992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。